The performance has "double declined" and the stock price "continues to fall". Why did bloomage biotechnology corporation limited's growth engine stall?

① Bloomage Biotechnology Corporation Limited once again experienced a double decline in revenue and net income in the first half of the year. The company achieved revenue of 2.81 billion yuan, a year-on-year decrease of 8.61%; achieved net income of 0.342 billion yuan, a year-on-year decrease of 19.51%; ② Although the raw materials business and medical terminal business performed well, the two major new sectors that have been heavily promoted in recent years - functional skincare products and functional food - have experienced a simultaneous decline in growth rates.

cls.cnAug 23 22:23 ET

The gross margin of injection products in the solution category has declined, and the imeik technology development's Q2 performance growth rate has dropped to single digits| Speed reading announcement.

①Imeik Technology Development's H1 revenue and net income growth rate slowed down. ②The gross margin of solution injection products has declined, and its proportion in total revenue has further decreased. ③In addition to laying out research and development pipelines for botulinum toxin, GLP-1 drugs, the company is also further expanding in the medical beauty equipment field.

cls.cnAug 21 10:16 ET

Meituan sets its sights on small businesses like nail salons.

Explore the potential of the industry chain.

wallstreetcnAug 2 08:22 ET

How long can the American customer love myth of high growth last? | Insight Research

Despite 3 consecutive years of high performance growth, market concerns about Aimeike's future growth momentum have not been resolved.

wallstreetcnMar 19 23:37 ET

Behind the slowdown in Aimeike's growth rate in the 3rd quarter: “Women's Maotai” can't handle the slump in consumption?

Demand weakens

wallstreetcnOct 25, 2023 03:55 ET

Medical beauty earns 200 million dollars a month and has to participate in the internal volume of diet pills. Where is the boundary of America's ambition?

It's not easy to take diet pills

wallstreetcnAug 24, 2023 13:11 ET